Experimental Tumor
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma (NCT03611231) | Peking University | 2018-09-01 |
| Chidamide for Patients With Recurrent and Metastatic Epstein-Barr Virus (EBV)-Associated Solid Tumors (NCT03494634) | Sun Yat-sen University | 2018-04-15 |
Track Experimental Tumor automatically
Every clearance here is in the API, with alerts when new ones post.